MOLECULAR TARGETS IN MALIGNANT LYMPHOMAS: FROM BASIC SCIENCE TO CLINICAL PRACTICE
mTOR inhibitors and beyond: Targeting a critical pathway
M. Dreyling
mTOR inhibitors and beyond: Targeting a critical pathway
M. Dreyling